Nordic Capital offers $846m to buy complex medicines specialist Advanz Pharma
Private equity major Nordic Capital has offered to buy complex medicines specialist Advanz Pharma in an $846m deal.
Private equity major Nordic Capital has offered to buy complex medicines specialist Advanz Pharma in an $846m deal.
Recent Comments